This is a "connection" page, showing publications co-authored by Sandeep Gurbuxani and Michael Drazer.
Clinical and molecular response of acute myeloid leukemia harboring non-canonical FLT3 N676K driver mutations to contemporary FLT3 inhibitors. Haematologica. 2023 Jan 19.
NPM1 exon 5 mutations in acute myeloid leukemia: Implications in diagnosis and minimal residual monitoring. EJHaem. 2022 Aug; 3(3):962-965.